Amlodipine
No difference in most long-term morbidity, mortality outcomes for three BP medications
In adults with hypertension and at least one CHD risk factor followed for up to 23 years, three antihypertensive medications did not differ in CVD mortality, according to long-term results of the ALLHAT trial.
Effectiveness of common blood pressure drugs varies widely
Blood pressure lowering with common antihypertension drugs varies widely among adults with hypertension, yet greater reductions are possible with personalized therapy, researchers reported.
Aggressive BP lowering reduces CV events in older adults with hypertension
Intensive treatment to a systolic BP target of 110 mm Hg to less than 130 mm Hg was associated with a 26% reduced risk for CV events in older adults with hypertension compared with standard BP management.
ASCOT: Amlodipine outperforms atenolol in stroke prevention
Long-term results from the ASCOT trial demonstrated that an amlodipine-based BP-lowering regimen reduced stroke risk compared with an atenolol-based regimen, although no benefit in dementia risk was observed.